Selling Smart: How to Market RUO Products Without Triggering FDA Oversight episode artwork

EPISODE · Nov 29, 2025 · 29 MIN

Selling Smart: How to Market RUO Products Without Triggering FDA Oversight

from A Splice of Life Science Marketing · host Matt Wilkinson and Jasmine Griuia-Gray | Strivenn

Your antibody copy could land you an FDA warning letter. One wrong phrase on your website transforms a research tool into an unapproved diagnostic device in the eyes of regulators.This conversation is for marketing managers at life science tools companies who need to promote Research Use Only (RUO) products without crossing regulatory lines. Josh Levin, former FDA compliance officer and diagnostics consultant, explains exactly which words trigger investigations and how to communicate analytical performance without implying diagnostic intent. Words matter: phrases like "used in diagnosis" or "detects disease" create regulatory risk; safer language references literature findings or analytical capabilities.What you will learn:The specific RUO disclaimer language FDA requires and where it must appearRed flag phrases that imply diagnostic claims versus safe alternatives that reference published researchWhy written website copy receives more FDA scrutiny than verbal sales conversationsHow to present clinical data and analytical performance without crossing into diagnostic territoryWhat compliance language belongs in distributor agreements to prevent off-label promotionThree strategic tips for tools companies considering entry into the diagnostic spaceChapters:[0:00] Introduction and defining Research Use Only[1:26] What RUO means and how FDA determines intended use[2:29] Required RUO statement placement and formatting[3:58] What manufacturers can and cannot say about RUO products[6:35] Red flag words versus safe phrasing for website copy[9:23] Framing analytical data without implying clinical validity[12:01] Application notes and case study guardrails[13:09] How AI might change FDA compliance monitoring[14:24] Working with diagnostic and clinical lab customers[21:38] Distributor compliance and partner training[22:51] Combined-function instruments and software considerations[26:13] Three tips for tools companies entering diagnosticsKeywords: Research Use Only, RUO products, FDA compliance, life science marketing, diagnostic claims, regulatory copywriting, antibody marketing, lab developed tests, ISO 13485, clinical lab regulations, tools manufacturer compliance, FDA warning lettersReady to ensure your marketing copy stays compliant? Watch this essential conversation, subscribe for more regulatory insights, and visit strivenn.com for expert guidance on life science marketing strategy.

Episode metadata supplied by the publisher feed · Published Nov 29, 2025

Embed this episode

NOW PLAYING

Selling Smart: How to Market RUO Products Without Triggering FDA Oversight

0:00 29:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of A Splice of Life Science Marketing?

This episode is 29 minutes long.

When was this A Splice of Life Science Marketing episode published?

This episode was published on November 29, 2025.

Can I download this A Splice of Life Science Marketing episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!